Neospark Drugs And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 15.50 Cr
- Company Age 35 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 95.79 Cr
- Satisfied Charges ₹ 21.29 Cr
- Revenue Growth -1.81%
- Profit Growth -18.22%
- Ebitda -19.01%
- Net Worth 31.99%
- Total Assets 19.34%
About Neospark Drugs And Chemicals
Neospark Drugs And Chemicals Private Limited. (NDACPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 June 1989 and has a history of 35 years and seven months. Its registered office is in Na, Telangana.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 15.50 Cr.
The company currently has active open charges totaling ₹95.79 Cr. The company has closed loans amounting to ₹21.29 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Neospark Drugs And Chemicals Private Limited. India is Sreekanth Chanda as COMPANY SECRETARY. Kumara Muppala, Siva Vemulapalli, Kalyan Kanaparti, and Seven other members serve as directors at the Company.
Company Details
- Location Na, Telangana
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230TG1989PTC010189
-
Company No.
010189
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jun 1989
-
Date of AGM
18 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Neospark Drugs And Chemicals Private Limited. offer?
Neospark Drugs And Chemicals Private Limited. offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement, Fish Foods, Antibiotic Tablets & Capsules, Cephalexin Tablets, Veterinary Medicines, Veterinary Drugs, API (Active Pharmaceutical Ingredients), Poultry Medicines, Powder Coatings.
Who are the key members and board of directors at Neospark Drugs And Chemicals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreekanth Chanda | Company Secretary | Current | |
Chandra Gannamaneni
|
Managing Director | 17-Aug-1994 | Current |
Board Members (9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Kalyan Kanaparti
|
Director | 18-May-2019 | Current |
Hari Vemulapalli
|
Director | 30-Apr-2021 | Current |
|
Ashok Uyyuru
|
Director | 18-May-2019 | Current |
|
Kumara Muppala
|
Whole-Time Director | 17-Aug-1994 | Current |
|
Siva Vemulapalli
|
Whole-Time Director | 04-Jun-1990 | Current |
|
Gannamaneni Indrani
|
Director | 18-May-2019 | Current |
Financial Performance of Neospark Drugs And Chemicals.
Neospark Drugs And Chemicals Private Limited., for the financial year ended 2023, experienced Minor drop in revenue, with a 1.81% decrease. The company also saw a substantial fall in profitability, with a 18.22% decrease in profit. The company's net worth Soared by an impressive increase of 31.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neospark Drugs And Chemicals?
In 2023, Neospark Drugs And Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Whitespace Health Private LimitedSiva Vemulapalli and Kalyan Kanaparti are mutual person
-
Neospark Pharma Private LimitedKumara Muppala, Siva Vemulapalli and 3 more are mutual person
-
Shaster Technologies Private LimitedSiva Vemulapalli and Kalyan Kanaparti are mutual person
Charges (Loans)
₹95.79 Cr
₹21.29 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 95.79 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2024 | State Bank Of India | ₹2.90 M | Open |
| 02 Mar 1994 | State Bank Of India | ₹95.50 Cr | Open |
| 24 Sep 2015 | Andhra Pradesh State Financial Corporation | ₹8.75 Cr | Satisfied |
| 16 Nov 2010 | Andhra Pradesh State Financial Corporation | ₹6.00 Cr | Satisfied |
| 29 May 2009 | Andhrapradesh State Financial Corporation | ₹1.50 Cr | Satisfied |
How Many Employees Work at Neospark Drugs And Chemicals?
Neospark Drugs And Chemicals has a workforce of 560 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neospark Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neospark Drugs And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
